These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8173579)

  • 21. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics].
    Syrenicz A
    Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neonatal hyperthyroidism in non-diagnosed Basedow's disease of the mother. Problems of diagnosis and therapy illustrated by a case history].
    Krüger C; Dörr HG; Becker W; Wolf F; Harms D
    Dtsch Med Wochenschr; 1994 Oct; 119(40):1346-50. PubMed ID: 7924939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and treatment of Basedow's disease].
    Nagataki S
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):322-5. PubMed ID: 1692077
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The many causes of subclinical hyperthyroidism.
    Charkes ND
    Thyroid; 1996 Oct; 6(5):391-6. PubMed ID: 8936661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioactive iodine in the treatment of Graves' disease.
    Al-Kaabi JM; Hussein SS; Bukheit CS; Woodhouse NJ; Elshafie OT; Bererhi H
    Saudi Med J; 2002 Sep; 23(9):1049-53. PubMed ID: 12370710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Echocardiographic study of hyperthyroidism based on 9 cases of Basedow's disease (author's transl)].
    Guillevin L; Scheuble C; Modigliani E; Sebaoun J
    Ann Med Interne (Paris); 1979; 130(4):205-10. PubMed ID: 582500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basedow's disease in a female patient with breast cancer metastasizing to the thyroid].
    Koev D; Chavrakov G; Koeva L; Khristozov K; Ivanova R
    Vutr Boles; 1987; 26(5):126-31. PubMed ID: 3433725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex investigation of Graves'-Basedow disease: case report.
    Luca IC; Bene MC; Cotuţiu C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The application of plasmapheresis for preoperative preparation of the child with Basedow's disease].
    Gostimskiĭ AV; Romanchishen AF; Peredereev SS
    Vestn Khir Im I I Grek; 2014; 173(3):82-3. PubMed ID: 25306642
    [No Abstract]   [Full Text] [Related]  

  • 35. [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].
    Döge H; Hübner O; Kempe K; Riedel A; Ortweiler W
    Z Gesamte Inn Med; 1993 Aug; 48(8):398-400. PubMed ID: 8379222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
    Vitti P; Rago T; Chiovato L; Pallini S; Santini F; Fiore E; Rocchi R; Martino E; Pinchera A
    Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
    Heberling HJ; Bierwolf B; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):301-6. PubMed ID: 2879721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basedow's disease and pregnancy].
    Luton JP; Guilhaume B
    Rev Prat; 1990 May; 40(15):1396-7. PubMed ID: 1694038
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves' disease and selective resistance of pituitary thyrotroph to thyroid hormone. A case report.
    Pillay NL; Jialal I; Govender PA; Green-Thompson RW; Joubert SM
    S Afr Med J; 1986 Sep; 70(6):360-1. PubMed ID: 3092372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.